![]() |
市場調查報告書
商品編碼
2044471
2034年睡眠改善食品市場預測-按產品類型、產品形式、性質、消費者群、通路和地區分類的全球分析Sleep-Enhancing Foods Market Forecasts to 2034 - Global Analysis By Product Type, Product Format, Nature, Consumer Group, Distribution Channel, and By Geography |
||||||
根據 Stratistics MRC 預測,全球睡眠改善食品市場預計將在 2026 年達到 33 億美元,並在預測期內以 8.7% 的複合年成長率成長,到 2034 年達到 64 億美元。
助眠食品是機能性食品,配方中添加了褪黑素、鎂、L-茶氨酸、洋甘菊、纈草根和其他適應原等成分,旨在幫助維持健康的睡眠模式並改善睡眠品質。該市場的目標族群日益成長,他們飽受失眠、壓力引起的睡眠障礙和晝夜節律紊亂的困擾。隨著消費者越來越傾向於尋找處方助眠藥物的天然替代品,這些以食品為基礎的解決方案提供了一種便捷且無成癮性的選擇,無需服用處方藥即可改善睡眠衛生。
全球睡眠障礙和壓力增加
據估計,全球約有三分之一的人口患有某種形式的睡眠障礙,這使得人們對簡單易行的非藥物解決方案的需求龐大。慢性壓力、睡前過度使用電子產品以及繁忙的工作安排共同導致了全球範圍內普遍存在的睡眠不足,影響著所有年齡層的人。從睡前飲品到睡前輕食,促進睡眠的食品提供了一種切實可行的日常解決方案,可以輕鬆融入夜間作息。醫療保健專業人員越來越認知到營養與睡眠品質之間的聯繫,並將機能性食品作為第一線干預措施。隨著人們對睡眠在整體健康中關鍵作用的認知不斷提高,消費者正在積極尋找能夠促進安穩睡眠且無副作用的產品。
缺乏關於有效性的科學證據
許多聲稱能改善睡眠的成分缺乏強力的、大規模的臨床試驗來證明其在不同人群中具有一致的效果,這導致消費者和醫療保健專業人員普遍持懷疑態度。雖然褪黑素仍然是研究最多的成分,但其他一些受歡迎的成分,例如睡茄和纈草根,在同行評審的研究中卻得出了結果不一或模棱兩可的結論。個體對助眠產品的反應因新陳代謝、潛在疾病和所需劑量而異,因此很難斷言其具有普遍的有效性。監管機構對機能性食品監管力道不斷加大,要求生產商投入昂貴的臨床研究。這種證據的缺乏損害了市場的信譽,並減緩了注重證據的消費者對產品的接受度。
營養基因組學和人工智慧驅動的個人化
基因檢測和人工智慧技術的進步,使得基於個人代謝特徵和睡眠類型進行前所未有的睡眠營養個人化成為可能。營養基因組學可以識別影響褪黑激素生成、咖啡因代謝和營養吸收的基因變異,從而提供個人化的配方提案。與穿戴式睡眠追蹤器整合的行動應用程式可以收集用戶數據,並根據識別出的睡眠模式紊亂情況,提案能夠有效改善睡眠的特定產品。這種精準的方法相比標準化解決方案顯著提高了有效性,使其能夠支撐較高的定價,並建立強大的品牌忠誠度。隨著消費者對個人化健康解決方案的需求日益成長,提供客製化睡眠營養的公司將佔據有利地位,加速發展。
活性成分監管方面的不確定性
全球不同司法管轄區對助眠化合物的分類差異顯著,這為國際市場擴張帶來了合規挑戰。褪黑素補充劑在一些國家被歸類為膳食補充劑,但在其他國家則需要獲得藥品核准,因為高劑量使用受到限制。像大麻二酚 (CBD) 這樣的新型助眠成分面臨著特別複雜的監管環境,其合法性和允許的功效聲明經常變化。不利事件報告或品管缺陷可能導致監管機構採取嚴厲措施,嚴重限制市場准入。製造商必須持續關注不斷變化的法規,並大力投資於合規體系,因為政策的突然變化可能同時對多個市場的業務造成重大干擾風險。
新冠疫情大大推動了助眠產品市場的發展,封鎖措施、健康焦慮和睡眠模式紊亂導致全球睡眠品質普遍下降。與疫情相關的失眠症(有時被稱為「新冠失眠症」)的報告在各個年齡層中激增,促使消費者尋求便捷的自我護理解決方案。儘管供應鏈中斷最初影響了原料供應,但需求迅速超過了疫情前的預期。在家工作的廣泛普及凸顯了睡眠對生產力和心理健康的重要性,消費者對助眠產品的認知也從單純的醫療介入轉變為將其視為重要的健康工具。這種消費者接受度的提升一直持續至今,即使在疫情高峰過後,市場需求依然居高不下。
在預測期內,軟糖和咀嚼片產品預計將佔據最大的市場佔有率。
預計在預測期內,軟糖和咀嚼片產品將佔據最大的市場佔有率,這主要得益於其便捷性、宜人的口味以及對追求舒適睡前習慣的消費者的吸引力。與可能給人以藥物印象的膠囊和片劑不同,軟糖提供類似糖果的服用體驗,降低了人們對服用助眠產品的心理抵觸情緒,因此尤其受到年輕人和初次使用助眠產品的人群的歡迎。此外,預先設定的單劑量包裝避免了粉末和液體萃取物中常見的計量誤差,確保了劑量的一致性。而且,與固態片劑相比,咀嚼片的吸收速度更快,其口味也減輕了活性成分的苦味,因此預計在整個預測期內,軟糖和咀嚼片將保持其市場優勢。
在預測期內,有機產品細分市場預計將實現最高的複合年成長率。
在預測期內,有機產品細分市場預計將呈現最高的成長率。這反映出消費者日益關注睡前攝取成分的合成農藥、化學殘留和整體純度。有機認證確保了洋甘菊、西番蓮和檸檬香蜂草等助眠植物成分的種植過程中不使用可能干擾睡眠品質的合成化學物質。注重健康的消費者越來越仔細地查看產品標籤,並傾向於選擇價格較高的有機產品,將額外的支出視為對睡眠健康的投資。隨著零售通路從天然食品店擴展到一般超市,有機睡眠產品正加速從傳統產品手中奪取市場佔有率。
在整個預測期內,北美預計將保持最大的市場佔有率,這主要得益於高壓力水平、營養補充劑的廣泛接受度以及機能性食品完善的分銷網路。該地區失眠症的高發生率和輪班工作文化導致助眠產品在各個年齡層中廣泛使用。強大的D2C(直接面對消費者)行銷能力和廣泛的電子商務滲透率使得產品能夠快速上市並進行消費者認知度宣傳活動。眾多創新新創公司以及投資睡眠相關產品線的成熟食品公司正加速該品類的發展。允許對食品成分進行結構和功能標籤標註的法規結構提供了行銷柔軟性,從而鞏固了北美在整個預測期內的領先地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於人們對草藥助眠產品的傳統接受度以及機能性食品製造的快速現代化。中國、日本和韓國等國家長期以來一直使用紅棗、遠志、靈芝等草藥成分來改善睡眠,這使得消費者自然而然地接受了現代產品形式。快速的都市化和電子設備的普及導致全部區域與壓力相關的睡眠障礙病例增加,擴大了目標市場。不斷壯大的中產階級願意為便捷且有科學根據的睡眠解決方案支付更高的價格。隨著國際品牌產品本土化和國內製造商產能的提升,亞太地區正成為睡眠改善食品市場成長最快的地區。
According to Stratistics MRC, the Global Sleep-Enhancing Foods Market is accounted for $3.3 billion in 2026 and is expected to reach $6.4 billion by 2034 growing at a CAGR of 8.7% during the forecast period. Sleep-enhancing foods are functional food products formulated with ingredients such as melatonin, magnesium, L-theanine, chamomile, valerian root, and other adaptogens specifically designed to support healthy sleep patterns and improve sleep quality. The market serves a growing population struggling with insomnia, stress-induced sleep disruption, and irregular circadian rhythms. As consumers increasingly seek natural alternatives to pharmaceutical sleep aids, these food-based solutions offer convenient, non-habit-forming options for improving sleep hygiene without prescription medications.
Rising global prevalence of sleep disorders and stress
An estimated one-third of the global population experiences some form of sleep disruption, creating massive demand for accessible, non-pharmaceutical interventions. Chronic stress, digital device overuse before bedtime, and demanding work schedules have contributed to a global sleep deprivation epidemic affecting all age groups. Sleep-enhancing foods offer a practical, daily-use solution that fits naturally into evening routines, from bedtime beverages to pre-sleep snacks. Healthcare professionals increasingly acknowledge the link between nutrition and sleep quality, recommending functional foods as first-line interventions. As awareness of sleep's critical role in overall health expands, consumers proactively seek products that support restful sleep without side effects.
Limited scientific validation of efficacy claims
Many sleep-enhancing ingredients lack robust, large-scale clinical trials demonstrating consistent results across diverse populations, creating skepticism among both consumers and healthcare professionals. Melatonin remains the most studied ingredient, but other popular components like ashwagandha and valerian root show mixed or inconclusive evidence in peer-reviewed research. Individual responses to sleep aids vary significantly based on metabolism, underlying health conditions, and dosage requirements, making generalized efficacy claims difficult to substantiate. Regulatory scrutiny of functional food claims continues to intensify, requiring manufacturers to invest in expensive clinical research. This evidence gap restricts market credibility and slows adoption among evidence-driven consumer segments.
Personalization through nutrigenomics and AI
Advancements in genetic testing and artificial intelligence are enabling unprecedented personalization of sleep nutrition based on individual metabolic profiles and chronotypes. Nutrigenomics allows identification of genetic variations affecting melatonin production, caffeine metabolism, and nutrient absorption, guiding tailored formulation recommendations. Mobile applications integrated with wearable sleep trackers can collect user data and suggest specific sleep-enhancing products based on identified sleep pattern disruptions. This precision approach dramatically improves efficacy compared to one-size-fits-all solutions, justifying premium pricing and building strong brand loyalty. As consumers increasingly expect personalized wellness solutions, companies offering customized sleep nutrition are positioned for accelerated growth.
Regulatory uncertainty surrounding active ingredients
The classification of sleep-enhancing compounds varies widely across global jurisdictions, creating compliance challenges for international market expansion. Melatonin supplements are regulated as dietary supplements in some countries but require pharmaceutical approval in others where higher doses are restricted. Newer ingredients like cannabidiol for sleep face particularly complex regulatory landscapes, with legality and permitted claims changing frequently. Potential regulatory crackdowns following adverse event reports or quality control failures could severely restrict market access. Manufacturers must continuously monitor evolving regulations and invest significantly in compliance infrastructure, with sudden policy changes posing substantial business disruption risks across multiple markets simultaneously.
The COVID-19 pandemic dramatically accelerated the sleep-enhancing foods market as lockdowns, health anxieties, and disrupted routines triggered widespread sleep deterioration globally. Reports of pandemic-related insomnia, often termed "coronasomnia," surged across all demographics, driving consumers toward accessible self-care solutions. Supply chain disruptions initially affected ingredient availability, but demand quickly outpaced pre-pandemic projections. Working-from-home arrangements highlighted the importance of sleep for productivity and mental health, shifting consumer attitudes from viewing sleep aids as medical interventions to recognizing them as essential wellness tools. This expanded consumer acceptance has proven durable, maintaining elevated demand levels beyond the acute pandemic period.
The Gummies & Chewables segment is expected to be the largest during the forecast period
The Gummies & Chewables segment is expected to account for the largest market share during the forecast period, driven by their convenience, pleasant taste, and appeal to consumers seeking a comfortable bedtime ritual. Unlike capsules or tablets that feel medicinal, gummies offer a candy-like consumption experience that reduces psychological resistance to taking sleep aids, making them particularly popular among younger adults and those new to sleep supplementation. Their portion-controlled format eliminates measuring errors common with powders or liquid extracts, ensuring consistent dosing. The chewable format also enables faster absorption compared to solid tablets, with flavors masking bitter notes of active ingredients, contributing to sustained dominance throughout the forecast timeline.
The Organic segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Organic segment is predicted to witness the highest growth rate, reflecting heightened consumer concerns about synthetic pesticides, chemical residues, and the overall purity of ingredients consumed before sleep. Organic certification provides assurance that sleep-enhancing botanicals like chamomile, passionflower, and lemon balm are grown without potentially disruptive synthetic chemicals that could interfere with sleep quality. Health-conscious consumers increasingly scrutinize product labels, preferring organic options despite premium pricing, viewing the additional cost as an investment in their sleep health. As retail distribution expands beyond specialty natural food stores into mainstream grocery channels, organic sleep products are capturing share from conventional alternatives at an accelerating pace.
During the forecast period, the North America region is expected to hold the largest market share, supported by high stress levels, widespread acceptance of dietary supplements, and sophisticated functional food distribution networks. The region's high prevalence of insomnia and shift work culture has normalized daily sleep aid consumption across broad age demographics. Strong direct-to-consumer marketing capabilities and extensive e-commerce penetration enable rapid product launches and consumer education campaigns. The presence of numerous innovative startups alongside established food corporations investing in sleep-focused product lines accelerates category development. Regulatory frameworks permitting structure-function claims for dietary ingredients provide marketing flexibility, cementing North America's leadership throughout the forecast period.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by traditional acceptance of herbal sleep remedies combined with rapid modernization of functional food manufacturing. Countries including China, Japan, and South Korea have long histories of using herbal ingredients like jujube seed, polygala, and reishi mushroom for sleep support, creating natural consumer receptivity to modern product formats. Rapid urbanization and digital device proliferation have increased stress-related sleep disorders across the region, expanding the addressable market. The growing middle class demonstrates willingness to pay premium prices for convenient, science-backed sleep solutions. As international brands localize offerings and domestic manufacturers upgrade production capabilities, Asia Pacific emerges as the fastest-growing market for sleep-enhancing foods.
Key players in the market
Some of the key players in Sleep-Enhancing Foods Market include Nestle S.A., Danone S.A., PepsiCo, Inc., The Coca-Cola Company, General Mills, Inc., Kellogg Company, Unilever PLC, Mondelez International, Inc., Yakult Honsha Co., Ltd., Otsuka Holdings Co., Ltd., Herbalife Ltd., Amway Corp., Nature's Bounty Co., Glanbia plc, Abbott Laboratories, NOW Health Group, Inc., and Hain Celestial Group, Inc.
In March 2026, Danone launched "Phase Two" of its Sustainability and Health roadmap, prioritizing Health through Food. This includes a new R&D initiative to develop probiotic strains that support the gut-brain axis, specifically targeting nighttime cortisol reduction.
In March 2026, under new operational leadership, Coca-Cola announced a digital-first strategy to scale its "Emerging Categories," which include relaxation and "smart" waters designed to compete in the growing functional beverage space in Asia and North America.
In December 2025, Nestle's Health Science division launched a series of high-protein, amino-acid-enriched snacks designed for evening consumption, aiming to stabilize blood sugar levels and promote better sleep quality in elderly demographics.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.